These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21619487)

  • 1. The Therapeutic Target Database: an internet resource for the primary targets of approved, clinical trial and experimental drugs.
    Liu X; Zhu F; Ma X; Tao L; Zhang J; Yang S; Wei Y; Chen YZ
    Expert Opin Ther Targets; 2011 Aug; 15(8):903-12. PubMed ID: 21619487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update of TTD: Therapeutic Target Database.
    Zhu F; Han B; Kumar P; Liu X; Ma X; Wei X; Huang L; Guo Y; Han L; Zheng C; Chen Y
    Nucleic Acids Res; 2010 Jan; 38(Database issue):D787-91. PubMed ID: 19933260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in exploration of therapeutic targets.
    Zheng CJ; Han LY; Yap CW; Xie B; Chen YZ
    Drug News Perspect; 2005 Mar; 18(2):109-27. PubMed ID: 15883620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information.
    Yang H; Qin C; Li YH; Tao L; Zhou J; Yu CY; Xu F; Chen Z; Zhu F; Chen YZ
    Nucleic Acids Res; 2016 Jan; 44(D1):D1069-74. PubMed ID: 26578601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DrugBank: a comprehensive resource for in silico drug discovery and exploration.
    Wishart DS; Knox C; Guo AC; Shrivastava S; Hassanali M; Stothard P; Chang Z; Woolsey J
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D668-72. PubMed ID: 16381955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.
    Li YH; Yu CY; Li XX; Zhang P; Tang J; Yang Q; Fu T; Zhang X; Cui X; Tu G; Zhang Y; Li S; Yang F; Sun Q; Qin C; Zeng X; Chen Z; Chen YZ; Zhu F
    Nucleic Acids Res; 2018 Jan; 46(D1):D1121-D1127. PubMed ID: 29140520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEC-net: the development of the European register of clinical trials on medicines for children.
    Santoro E; Rossi V; Pandolfini C; Bonati M
    Clin Trials; 2006; 3(4):366-75. PubMed ID: 17060211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery.
    Zhu F; Shi Z; Qin C; Tao L; Liu X; Xu F; Zhang L; Song Y; Liu X; Zhang J; Han B; Zhang P; Chen Y
    Nucleic Acids Res; 2012 Jan; 40(Database issue):D1128-36. PubMed ID: 21948793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHMIS-C: a comprehensive herbal medicine information system for cancer.
    Fang X; Shao L; Zhang H; Wang S
    J Med Chem; 2005 Mar; 48(5):1481-8. PubMed ID: 15743190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and problems in the exploration of therapeutic targets.
    Zheng C; Han L; Yap CW; Xie B; Chen Y
    Drug Discov Today; 2006 May; 11(9-10):412-20. PubMed ID: 16635803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug development for cancer chemoprevention: focus on molecular targets.
    Johnson KA; Brown PH
    Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Representation and analysis of molecular networks involving diseases and drugs.
    Kanehisa M
    Genome Inform; 2009 Oct; 23(1):212-3. PubMed ID: 20180276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-iDT : tool for identification of drug target in bacteria and validation by Mycobacterium tuberculosis.
    Singh NK; Selvam SM; Chakravarthy P
    In Silico Biol; 2006; 6(6):485-93. PubMed ID: 17518759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae.
    González-Díaz H; Prado-Prado F; García-Mera X; Alonso N; Abeijón P; Caamaño O; Yáñez M; Munteanu CR; Pazos A; Dea-Ayuela MA; Gómez-Muñoz MT; Garijo MM; Sansano J; Ubeira FM
    J Proteome Res; 2011 Apr; 10(4):1698-718. PubMed ID: 21184613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of current pharmaceutical industry practices for making clinical trial results publicly accessible.
    Viereck C; Boudes P
    Contemp Clin Trials; 2009 Jul; 30(4):293-9. PubMed ID: 19348964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inspirations from natural products based drug research and development for Chinese medicine research--analysis of natural products recoded in TTD].
    Chen XP; Lu JJ; Guo JJ; Bao JL; Xu WS; Ding Q; Wang YT
    Yao Xue Xue Bao; 2012 Nov; 47(11):1423-7. PubMed ID: 23387071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The druggable genome: Evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication.
    Rask-Andersen M; Masuram S; Schiöth HB
    Annu Rev Pharmacol Toxicol; 2014; 54():9-26. PubMed ID: 24016212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy for the development of novel anticancer drugs.
    Saijo N; Tamura T; Nishio K
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S97-101. PubMed ID: 12856152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.